Class information for:
Level 1: LCK INHIBITOR//SRC INHIBITORS//SRC

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10628 980 46.5 90%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2824 2502 TETRASPANIN//CD9//CD151

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LCK INHIBITOR Author keyword 20 100% 1% 9
2 SRC INHIBITORS Author keyword 19 71% 2% 15
3 SRC Author keyword 18 10% 17% 165
4 AZD0530 Author keyword 15 82% 1% 9
5 SARACATINIB Author keyword 14 57% 2% 16
6 SRC KINASE INHIBITORS Author keyword 12 86% 1% 6
7 SRC INHIBITOR Author keyword 9 59% 1% 10
8 SRC KINASE INHIBITOR Author keyword 8 75% 1% 6
9 DASATINIB Author keyword 8 12% 7% 66
10 C SRC Author keyword 7 13% 6% 55

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LCK INHIBITOR 20 100% 1% 9 Search LCK+INHIBITOR Search LCK+INHIBITOR
2 SRC INHIBITORS 19 71% 2% 15 Search SRC+INHIBITORS Search SRC+INHIBITORS
3 SRC 18 10% 17% 165 Search SRC Search SRC
4 AZD0530 15 82% 1% 9 Search AZD0530 Search AZD0530
5 SARACATINIB 14 57% 2% 16 Search SARACATINIB Search SARACATINIB
6 SRC KINASE INHIBITORS 12 86% 1% 6 Search SRC+KINASE+INHIBITORS Search SRC+KINASE+INHIBITORS
7 SRC INHIBITOR 9 59% 1% 10 Search SRC+INHIBITOR Search SRC+INHIBITOR
8 SRC KINASE INHIBITOR 8 75% 1% 6 Search SRC+KINASE+INHIBITOR Search SRC+KINASE+INHIBITOR
9 DASATINIB 8 12% 7% 66 Search DASATINIB Search DASATINIB
10 C SRC 7 13% 6% 55 Search C+SRC Search C+SRC

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 C SRC 49 14% 34% 334
2 FAMILY KINASES 46 21% 20% 196
3 PP60C SRC PROTEIN KINASE 41 51% 6% 57
4 4 PHENYLAMINO 3 QUINOLINECARBONITRILES 33 83% 2% 19
5 ADVANCED COLORECTAL CANCERS 27 92% 1% 11
6 ABL KINASES 14 59% 2% 16
7 CONSTRAINED PEPTIDE ANALOGS 12 86% 1% 6
8 P56LCK INHIBITORS 10 73% 1% 8
9 FAMILY KINASE INHIBITOR 10 58% 1% 11
10 SARACATINIB AZD0530 9 67% 1% 8

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph 2012 47 58 57%
SRC: A Century of Science Brought to the Clinic 2010 96 74 64%
Translational evidence on the role of Src kinase and activated Src kinase in invasive breast cancer 2014 5 40 83%
Src kinases as therapeutic targets for cancer 2009 263 90 38%
Src family kinases in tumor progression and metastasis 2003 464 164 41%
Src Signaling in Cancer Invasion 2010 147 110 32%
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors 2010 52 62 63%
The Role of Src in Solid Tumors 2009 103 86 53%
A renaissance for SRC 2004 557 101 37%
Targeting Src in breast cancer 2008 98 64 48%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CHEM SCI ONCOL 6 100% 0.4% 4
2 SEZ NEUROIMMUNOFISIOL 6 100% 0.4% 4
3 IMMUNOL INFLAMMAT PULM DRUG DISCOVERY 1 31% 0.4% 4
4 ARTHRIT BONE METAB THER EUT AREA 1 38% 0.3% 3
5 CANC BIOL 179 1 50% 0.2% 2
6 INFLAMMAT ASSOCIATED CARCINOGENESIS 1 100% 0.2% 2
7 PHARMACOCHEM TECHNOL 1 50% 0.2% 2
8 THER EUT AREA ARTHRIT BONE METAB 1 100% 0.2% 2
9 CHEM SCREENING SCI ONCOL 1 40% 0.2% 2
10 DEV MED REPROD MATERNAL MED 1 40% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000192843 CDCP1//TRASK//SUBTRACTIVE IMMUNIZATION
2 0.0000150856 C FGR//TYROSINE PROTEIN KINASE//CSK
3 0.0000096266 ANILINOQUINAZOLINE//COMBI MOLECULE//CANC DRUG
4 0.0000094888 FOCAL ADHESION KINASE//FAK//PYK2
5 0.0000077690 GRB2//SH2 DOMAIN//SH3 DOMAIN
6 0.0000077155 STRIATAL ENRICHED PROTEIN TYROSINE PHOSPHATASE//FYN TYROSINE KINASE//PROGRAMME BRAIN BEHAV
7 0.0000076714 NECDIN//REGULAT MACROMOL FUNCT//REGULAT NEURONAL DEV
8 0.0000071394 CAPK//CAMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT//PATHOCHEM
9 0.0000066765 PODOSOMES//INVADOPODIA//CORTACTIN
10 0.0000062686 CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB